Desciclovir

This classification denotes a purine antagonist and antiviral agent with the molecular formula C8H11N5O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier BHM1XXA2EZ, chemically known as ethanol, 2-((2-amino-9h-purin-9-yl)methoxy)- but generally known as desciclovir, which bears US NIH Compound Identifier 55256. European Medicines Agency schedules Desciclovir in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06990MIG. The term DESCICLOVIR is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 40, No. 6, 1986, List 26). DESCICLOVIR is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule desciclovir under HS 29335995 and SITC 51576. As of Q4 2014, DESCICLOVIR remains the US FDA Preferred Term for this commodity. Desciclovir bears US NLM identifiers UMLS ID C0113168 and NCI Concept Code C73203. SMILES: O(CN1C2NC(NCC2NC1)N)CCO.